Ardent Health Partners’ (ARDT) Overweight Rating Reiterated at Stephens

Stephens reiterated their overweight rating on shares of Ardent Health Partners (NYSE:ARDT) in a research note published on Wednesday morning,Benzinga reports. Stephens currently has a $22.00 price objective on the stock.

A number of other equities research analysts have also weighed in on ARDT. Royal Bank of Canada reduced their price objective on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Tuesday, March 4th. Morgan Stanley cut their price target on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Finally, Truist Financial cut their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Ardent Health Partners currently has a consensus rating of “Buy” and an average target price of $21.18.

Ardent Health Partners Trading Down 0.2 %

Shares of NYSE ARDT opened at $13.09 on Wednesday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The stock’s 50-day moving average is $14.44 and its two-hundred day moving average is $16.30. Ardent Health Partners has a 1-year low of $12.87 and a 1-year high of $20.72.

Ardent Health Partners (NYSE:ARDT) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion. Analysts anticipate that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in ARDT. Charles Schwab Investment Management Inc. purchased a new position in Ardent Health Partners during the 3rd quarter worth $526,000. BNP Paribas Financial Markets purchased a new position in shares of Ardent Health Partners during the third quarter worth about $42,000. MetLife Investment Management LLC acquired a new position in Ardent Health Partners in the 3rd quarter valued at about $135,000. Goldentree Asset Management LP purchased a new stake in Ardent Health Partners during the 3rd quarter valued at approximately $22,897,000. Finally, Centiva Capital LP purchased a new stake in Ardent Health Partners during the 3rd quarter valued at approximately $469,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.